诺如病毒流行病学及疾病负担研究进展

朱曦 靳淼 段招军

朱曦, 靳淼, 段招军. 诺如病毒流行病学及疾病负担研究进展[J]. 疾病监测, 2021, 36(8): 769-773. doi: 10.3784/jbjc.202106230362
引用本文: 朱曦, 靳淼, 段招军. 诺如病毒流行病学及疾病负担研究进展[J]. 疾病监测, 2021, 36(8): 769-773. doi: 10.3784/jbjc.202106230362
Zhu Xi, Jin Miao, Duan Zhaojun. Research progress on the epidemiology and disease burden of norovirus[J]. Disease Surveillance, 2021, 36(8): 769-773. doi: 10.3784/jbjc.202106230362
Citation: Zhu Xi, Jin Miao, Duan Zhaojun. Research progress on the epidemiology and disease burden of norovirus[J]. Disease Surveillance, 2021, 36(8): 769-773. doi: 10.3784/jbjc.202106230362

诺如病毒流行病学及疾病负担研究进展

doi: 10.3784/jbjc.202106230362
基金项目: 国家科技重大专项(No. 2017ZXl0104001–003–001)
详细信息
    作者简介:

    朱曦,女,湖北省荆州市人,硕士,主要从事全国诺如病毒暴发和散发监测及毒株变异规律研究,Email:656706711@qq.com

    通讯作者:

    靳淼,Tel:010–58900180,Email:jinmiao37@126.com

  • 中图分类号: R211; R373.2

Research progress on the epidemiology and disease burden of norovirus

Funds: This study was supported by the Science and Technology Major Project (No. 2017ZX10104001–003–001)
More Information
  • 摘要: 诺如病毒是世界范围内引起急性胃肠炎散发和暴发病例的主要病原体,无论在发达国家还是发展中国家均造成严重的疾病负担。 本文分析诺如病毒的流行病学特点及疾病负担,对于加强诺如病毒防治和指导疫苗的研发具有重要意义。
  • [1] Lopman BA, Steele D, Kirkwood CD, et al. The vast and varied global burden of norovirus: prospects for prevention and control[J]. PLoS Med, 2016, 13(4): e1001999. DOI:  10.1371/journal.pmed.1001999.
    [2] GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2015, 385(9963): 117–171. DOI: 10.1016/S0140−6736(14)61682−2.
    [3] Pires SM, Fischer-Walker CL, Lanata CF, et al. Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food[J]. PLoS One, 2015, 10(12): e0142927. DOI:  10.1371/journal.pone.0142927.
    [4] Bucardo F, Reyes Y, Svensson L, et al. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination[J]. PLoS One, 2014, 9(5): e98201. DOI:  10.1371/journal.pone.0098201.
    [5] Payne DC, Vinjé J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U. S. children[J]. N Engl J Med, 2013, 368(12): 1121–1130. DOI:  10.1056/NEJMsa1206589.
    [6] Kirk MD, Pires SM, Black RE, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, Protozoal, and viral diseases, 2010: a data synthesis[J]. PLoS Med, 2015, 12(12): e1001921. DOI:  10.1371/journal.pmed.1001921.
    [7] Platts-Mills JA, Babji S, Bodhidatta L, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED)[J]. Lancet Glob Health, 2015, 3(9): e564–575. DOI: 10.1016/S2214−109X(15)00151−5.
    [8] Bartsch SM, Lopman BA, Ozawa S, et al. Global economic burden of norovirus gastroenteritis[J]. PLoS One, 2016, 11(4): e0151219. DOI:  10.1371/journal.pone.0151219.
    [9] Ahmed SM, Hall AJ, Robinson AE, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis[J]. Lancet Infect Dis, 2014, 14(8): 725–730. DOI: 10.1016/S1473−3099(14)70767−4.
    [10] Quee FA, de Hoog MLA, Schuurman R, et al. Community burden and transmission of acute gastroenteritis caused by norovirus and rotavirus in the Netherlands (RotaFam): a prospective household-based cohort study[J]. Lancet Infect Dis, 2020, 20(5): 598–606. DOI: 10.1016/S1473−3099(20)30058−X.
    [11] Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States[J]. Emerg Infect Dis, 2013, 19(8): 1198–1205. DOI:  10.3201/eid1908.130465.
    [12] Phillips G, Tam CC, Conti S, et al. Community incidence of norovirus-associated infectious intestinal disease in England: improved estimates using viral load for norovirus diagnosis[J]. Am J Epidemiol, 2010, 171(9): 1014–1022. DOI:  10.1093/aje/kwq021.
    [13] Scallan E, Griffin PM, Angulo FJ, et al. Foodborne illness acquired in the United States—major pathogens[J]. Emerg Infect Dis, 2011, 17(1): 7–15. DOI:  10.3201/eid1701.P21101.
    [14] Tam CC, Rodrigues LC, Viviani L, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice[J]. Gut, 2012, 61(1): 69–77. DOI:  10.1136/gut.2011.238386.
    [15] Thomas MK, Murray R, Flockhart L, et al. Estimates of the burden of foodborne illness in Canada for 30 specified pathogens and unspecified agents, circa 2006[J]. Foodborne Pathog Dis, 2013, 10(7): 639–648. DOI:  10.1089/fpd.2012.1389.
    [16] Verhoef L, Koopmans M, Van Pelt W, et al. The estimated disease burden of norovirus in the Netherlands[J]. Epidemiol Infect, 2013, 141(3): 496–506. DOI:  10.1017/S0950268812000799.
    [17] Saito M, Goel-Apaza S, Espetia S, et al. Multiple norovirus infections in a birth cohort in a Peruvian Periurban community[J]. Clin Infect Dis, 2014, 58(4): 483–491. DOI:  10.1093/cid/cit763.
    [18] Bierhoff M, Arvelo W, Estevez A, et al. Incidence and clinical profile of Norovirus disease in Guatemala, 2008–2013[J]. Clin Infect Dis, 2018, 67(3): 430–436. DOI:  10.1093/cid/ciy091.
    [19] Lanata CF, Fischer-Walker CL, Olascoaga AC, et al. Global causes of diarrheal disease mortality in children <5 years of age: a systematic review[J]. PLoS One, 2013, 8(9): e72788. DOI:  10.1371/journal.pone.0072788.
    [20] Harris JP, Iturriza-Gomara M, O'Brien SJ. Estimating disability-adjusted life Years (DALYs) in community cases of Norovirus in England[J]. Viruses, 2019, 11(2): 184. DOI:  10.3390/v11020184.
    [21] Gibney KB, O’toole J, Sinclair M, et al. Disease burden of selected gastrointestinal pathogens in Australia, 2010[J]. Int J Infect Dis, 2014, 28: 176–185. DOI:  10.1016/j.ijid.2014.08.006.
    [22] Mangen MJJ, Bouwknegt M, Friesema IHM, et al. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011[J]. Int J Food Microbiol, 2015, 196: 84–93. DOI:  10.1016/j.ijfoodmicro.2014.11.022.
    [23] Scallan E, Hoekstra RM, Mahon BE, et al. Scallan E, Hoekstra RM, Mahon BE, et al. An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years[J]. Epidemiol Infect, 2015, 143(13): 2795–2804. DOI:  10.1017/S0950268814003185.
    [24] Zhou HL, Zhen SS, Wang JX, et al. Burden of acute gastroenteritis caused by norovirus in China: A systematic review[J]. J Infect, 2017, 75(3): 216–224. DOI:  10.1016/j.jinf.2017.06.004.
    [25] Grytdal SP, Debess E, Lee LE, et al. Incidence of Norovirus and other viral pathogens that cause acute gastroenteritis (AGE) among Kaiser Permanente member populations in the United States, 2012-2013[J]. PLoS One, 2016, 11(4): e0148395. DOI:  10.1371/journal.pone.0148395.
    [26] Kobayashi S, Fujiwara N, Takeda N, et al. Seroepidemiological study of norovirus infection in Aichi Prefecture, Japan[J]. Microbiol Immunol, 2009, 53(6): 356–359. DOI: 10.1111/j.1348−0421.2009.00132.x.
    [27] Nurminen K, Blazevic V, Huhti L, et al. Prevalence of norovirus GⅡ-4 antibodies in Finnish children[J]. J Med Virol, 2011, 83(3): 525–531. DOI:  10.1002/jmv.21990.
    [28] Son H, Jeong HS, Cho M, et al. Seroepidemiology of predominant norovirus strains circulating in Korea by using recombinant virus-like particle antigens[J]. Foodborne Pathog Dis, 2013, 10(5): 461–466. DOI:  10.1089/fpd.2012.1300.
    [29] Mesquita JR, Nascimento MSJ. Norovirus GⅡ. 4 antibodies in the Portuguese population[J]. J Infect Dev Ctries, 2014, 8(9): 1201–1204. DOI:  10.3855/jidc.4616.
    [30] Carmona-Vicente N, Fernández-Jiménez M, Ribes JM, et al. Norovirus infections and seroprevalence of genotype GⅡ.4-specific antibodies in a Spanish population[J]. J Med Virol, 2015, 87(4): 675–682. DOI:  10.1002/jmv.24112.
    [31] Liu XH, Liu PB, Wang J, et al. Seroepidemiology of norovirus GⅡ.3 and GⅡ.4 infections in children with Diarrhea in Xi'an, China[J]. Foodborne Pathog Dis, 2015, 12(6): 500–505. DOI:  10.1089/fpd.2014.1905.
    [32] Kulkarni R, Lole K, Chitambar SD. Seroprevalence of antibodies against GⅡ.4 norovirus among children in Pune, India[J]. J Med Virol, 2016, 88(9): 1636–1640. DOI:  10.1002/jmv.24495.
    [33] van Beek J, de Graaf M, Xia M, et al. Comparison of norovirus genogroup Ⅰ, Ⅱ and Ⅳ seroprevalence among children in the Netherlands, 1963, 1983 and 2006[J]. J Gen Virol, 2016, 97(9): 2255–2264. DOI:  10.1099/jgv.0.000533.
    [34] Mans J. Longitudinal Seroprevalence study elucidates high norovirus burden in Sub-Saharan Africa[J]. J Infect Dis, 2018, 218(5): 676–678. DOI:  10.1093/infdis/jiy220.
    [35] Thorne L, Nalwoga A, Mentzer AJ, et al. The first norovirus longitudinal Seroepidemiological study from Sub-Saharan Africa reveals high Seroprevalence of diverse genotypes associated with host susceptibility factors[J]. J Infect Dis, 2018, 218(5): 716–725. DOI:  10.1093/infdis/jiy219.
    [36] Shioda K, Kambhampati A, Hall AJ, et al. Global age distribution of pediatric norovirus cases[J]. Vaccine, 2015, 33(33): 4065–4068. DOI:  10.1016/j.vaccine.2015.05.051.
    [37] Kambhampati A, Koopmans M, Lopman BA. Burden of norovirus in healthcare facilities and strategies for outbreak control[J]. J Hosp Infect, 2015, 89(4): 296–301. DOI:  10.1016/j.jhin.2015.01.011.
    [38] Cho HW, Chu C. Norovirus outbreaks occurred in different settings in the Republic of Korea[J]. Osong Public Health Res Perspect, 2015, 6(5): 281–282. DOI:  10.1016/j.phrp.2015.11.001.
    [39] Thongprachum A, Khamrin P, Maneekarn N, et al. Epidemiology of gastroenteritis viruses in Japan: Prevalence, seasonality, and outbreak[J]. J Med Virol, 2016, 88(4): 551–570. DOI:  10.1002/jmv.24387.
    [40] Jin M, Wu SY, Kong XY, et al. Norovirus outbreak surveillance, China, 2016–2018[J]. Emerg Infect Dis, 2020, 26(3): 437–445. DOI:  10.3201/EID2603.191183.
    [41] Ahmed SM, Lopman BA, Levy K. A systematic review and meta-analysis of the global seasonality of norovirus[J]. PLoS One, 2013, 8(10): e75922. DOI:  10.1371/journal.pone.0075922.
    [42] Chhabra P, Graaf MD, Parra GI, et al. Updated classification of norovirus genogroups and genotypes[J]. J Gen Virol, 2019, 100(10): 1393–1406. DOI:  10.1099/jgv.0.001318.
    [43] Cannon JL, Barclay L, Collins NR, et al. Genetic and epidemiologic trends of norovirus outbreaks in the united states from 2013 to 2016 demonstrated emergence of Novel GⅡ.4 recombinant viruses[J]. J Clin Microbiol, 2017, 55(7): 2208–2221. DOI: 10.1128/JCM.00455−17.
    [44] van Beek J, de Graaf M, Al-Hello H, et al. Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network[J]. Lancet Infect Dis, 2018, 18(5): 545–553. DOI: 10.1016/S1473−3099(18)30059−8.
    [45] Chan MCW, Lee N, Hung TN, et al. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GⅡ.17 variant in late 2014[J]. Nat Commun, 2015, 6: 10061. DOI:  10.1038/ncomms10061.
    [46] Lu J, Fang L, Sun LM, et al. Association of GⅡ. P16-GⅡ.2 recombinant norovirus strain with increased norovirus outbreaks, Guangdong, China, 2016[J]. Emerg Infect Dis, 2017, 23(7): 1188–1190. DOI:  10.3201/eid2307.170333.
    [47] Cates JE, Vinjé J, Parashar U, et al. Recent advances in human norovirus research and implications for candidate vaccines[J]. Exp Rev Vaccines, 2020, 19(6): 539–548. DOI:  10.1080/14760584.2020.1777860.
    [48] Pogan R, Dülfer J, Uetrecht C. Norovirus assembly and stability[J]. Curr Opin Virol, 2018, 31: 59–65. DOI:  10.1016/j.coviro.2018.05.003.
    [49] Barclay L, Cannon JL, Wikswo ME, et al. Emerging novel GⅡ. P16 noroviruses associated with multiple capsid genotypes[J]. Viruses, 2019, 11(6): 535. DOI:  10.3390/v11060535.
    [50] Allen DJ, Trainor E, Callaghan A, et al. Early detection of epidemic GⅡ-4 norovirus strains in UK and Malawi: role of surveillance of sporadic acute gastroenteritis in anticipating global epidemics[J]. PLoS One, 2016, 11(4): e0146972. DOI:  10.1371/journal.pone.0146972.
    [51] Bartsch SM, O'Shea KJ, Lee BY. The clinical and economic burden of norovirus gastroenteritis in the United States[J]. J Infect Dis, 2020, 222(11): 1910–1919. DOI:  10.1093/infdis/jiaa292.
  • 加载中
计量
  • 文章访问数:  158
  • HTML全文浏览量:  54
  • PDF下载量:  51
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-06-23
  • 网络出版日期:  2021-08-18
  • 刊出日期:  2021-08-31

目录

    /

    返回文章
    返回

    在线交流

    防诈骗公告

    近期有不法分子以本刊编辑身份添加作者微信,请务必提高警惕!本刊关于稿件的一切事项通知均采用编辑部唯一邮箱(jbjc@icdc.cn)和座机(010-58900732)联系作者,且在录用稿件后仅收取版面费,无其他任何名目费用(如审稿费和加急费等),非编辑部邮箱发送的本刊收费用通知等均为诈骗,不要随意汇入款项!如有可疑及时致电编辑部核实确认!